{"disease":{"id":"hematopoetic-myelodysplasia","name":"hematopoetic myelodysplasia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06904066","title":"Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":86,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT01720264","title":"Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Sherif S. Farag","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}